Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Dow
Baxter
Harvard Business School
Merck

Last Updated: August 15, 2022

Pharmaceutical drugs supplied by: AbbVie Inc.


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


AbbVie Inc.

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Abbvie ANDROGEL testosterone GEL, METERED;TRANSDERMAL 021015 NDA AbbVie Inc. 0051-8425-30 30 PACKET in 1 CARTON (0051-8425-30) > 2.5 g in 1 PACKET (0051-8425-01) 2011-03-14
Abbvie ANDROGEL testosterone GEL;TRANSDERMAL 021015 NDA AbbVie Inc. 0051-8425-30 30 PACKET in 1 CARTON (0051-8425-30) > 2.5 g in 1 PACKET (0051-8425-01) 2011-03-14
Abbvie ANDROGEL testosterone GEL, METERED;TRANSDERMAL 021015 NDA AbbVie Inc. 0051-8450-30 30 PACKET in 1 CARTON (0051-8450-30) > 5 g in 1 PACKET (0051-8450-01) 2011-03-14
Abbvie ANDROGEL testosterone GEL;TRANSDERMAL 021015 NDA AbbVie Inc. 0051-8450-30 30 PACKET in 1 CARTON (0051-8450-30) > 5 g in 1 PACKET (0051-8450-01) 2011-03-14
Abbvie ANDROGEL testosterone GEL, METERED;TRANSDERMAL 022309 NDA AbbVie Inc. 0051-8462-33 1 BOTTLE, PUMP in 1 CARTON (0051-8462-33) > 88 g in 1 BOTTLE, PUMP 2011-04-29
Abbvie ANDROGEL testosterone GEL;TRANSDERMAL 022309 NDA AbbVie Inc. 0051-8462-33 1 BOTTLE, PUMP in 1 CARTON (0051-8462-33) > 88 g in 1 BOTTLE, PUMP 2011-04-29
Abbvie Inc ORILISSA elagolix sodium TABLET;ORAL 210450 NDA AbbVie Inc. 0074-0038-01 1 BLISTER PACK in 1 CARTON (0074-0038-01) > 7 TABLET, FILM COATED in 1 BLISTER PACK 2018-07-23
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Subscribe to access the full database, or Try it Free

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
McKinsey
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2022 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2022 - 2023
 NCE-1 Patent Challenge Dates 2022 - 2023
 ClinicalTrialExchange - Connecting volunteers and trials
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group